Watch For Semglee to Be "Interchangeable" With Lantus
September 2021
Semglee (insulin glargine-yfgn U-100) will be the first "interchangeable" biosimilar.
It was originally approved as a new brand of insulin glargine, not a Lantus generic...and switching required a new Rx.
Now Semglee is both biosimilar to, and interchangeable with, Lantus. Biosimilars have to show similar safety, purity, and potency as the original, or "reference," biologic.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote